These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alpha-ketoglutaramate, a neurotoxic agent in hepatic coma. Vergara F; Duffy TE; Plum F Trans Assoc Am Physicians; 1973; 86():255-63. PubMed ID: 4788800 [No Abstract] [Full Text] [Related]
3. Recognition and management of acute and chronic hepatic encephalopathy. Jacobson S; Bell B Med Clin North Am; 1973 Nov; 57(6):1569-77. PubMed ID: 4583596 [No Abstract] [Full Text] [Related]
4. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy]. Sala Felis T; Berenguer J; Barrios JM; Gómez J Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021 [No Abstract] [Full Text] [Related]
5. [Therapy of hepatic encephalopathy. Personal experience and a review of the literature]. Cipollini F; Amadio R; Altilia F G Clin Med; 1982 Oct; 63(10):753-67. PubMed ID: 6133806 [No Abstract] [Full Text] [Related]
7. Hepatic encephalopathy: pathophysiology and emerging therapies. Sundaram V; Shaikh OS Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116 [TBL] [Abstract][Full Text] [Related]
8. Hypernatremia and lactulose therapy. Nelson DC; McGrew WR; Hoyumpa AM JAMA; 1983 Mar; 249(10):1295-8. PubMed ID: 6827705 [TBL] [Abstract][Full Text] [Related]
9. Alpha-ketoglutaramate in hepatic encephalopathy. Duffy TE; Vergara F; Plum F Res Publ Assoc Res Nerv Ment Dis; 1974; 53():39-52. PubMed ID: 4438817 [No Abstract] [Full Text] [Related]
10. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)]. Leonhardt H; Sanhueza P Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058 [No Abstract] [Full Text] [Related]
11. [Emergency treatment of hepatic coma and porto-caval encephalopathy]. Imler M Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):239-55. PubMed ID: 4589247 [No Abstract] [Full Text] [Related]
13. Portal-systemic encephalopathy and hepatic coma. Jensen DM Med Clin North Am; 1986 Sep; 70(5):1081-92. PubMed ID: 2874273 [TBL] [Abstract][Full Text] [Related]
14. Lactulose in the treatment of acute hepatic encephalopathy. Fessel JM; Conn HO Am J Med Sci; 1973 Aug; 266(2):103-10. PubMed ID: 4742364 [No Abstract] [Full Text] [Related]
15. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049 [TBL] [Abstract][Full Text] [Related]
17. Portal systemic encephalopathy--should lactulose and neomycin be used together. Martin AJ Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185 [No Abstract] [Full Text] [Related]
18. Hepatic encephalopathy. Davidoff S; Werbitt W J Med Soc N J; 1982 Nov; 79(12):919-22. PubMed ID: 6960190 [No Abstract] [Full Text] [Related]
19. [The level of ammonia and its metabolites in the brain in experimental hepatic encephalopathy induced by long-term administration of thioacetamine and during recovery]. Hilgier W; Albrecht J Neuropatol Pol; 1984; 22(2):179-84. PubMed ID: 6483197 [No Abstract] [Full Text] [Related]